These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

868 related items for PubMed ID: 30177023

  • 1. Murine Models of Human IgA Nephropathy.
    Suzuki H, Suzuki Y.
    Semin Nephrol; 2018 Sep; 38(5):513-520. PubMed ID: 30177023
    [Abstract] [Full Text] [Related]

  • 2. Development of Animal Models of Human IgA Nephropathy.
    Suzuki H, Suzuki Y, Novak J, Tomino Y.
    Drug Discov Today Dis Models; 2014 Sep; 11():5-11. PubMed ID: 25722731
    [Abstract] [Full Text] [Related]

  • 3. Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction.
    Papista C, Lechner S, Ben Mkaddem S, LeStang MB, Abbad L, Bex-Coudrat J, Pillebout E, Chemouny JM, Jablonski M, Flamant M, Daugas E, Vrtovsnik F, Yiangou M, Berthelot L, Monteiro RC.
    Kidney Int; 2015 Aug; 88(2):276-85. PubMed ID: 25807036
    [Abstract] [Full Text] [Related]

  • 4. Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice.
    Launay P, Grossetête B, Arcos-Fajardo M, Gaudin E, Torres SP, Beaudoin L, Patey-Mariaud de Serre N, Lehuen A, Monteiro RC.
    J Exp Med; 2000 Jun 05; 191(11):1999-2009. PubMed ID: 10839814
    [Abstract] [Full Text] [Related]

  • 5. Critical Role of Kupffer Cell CD89 Expression in Experimental IgA Nephropathy.
    Xu L, Li B, Huang M, Xie K, Li D, Li Y, Gu H, Fang J.
    PLoS One; 2016 Jun 05; 11(7):e0159426. PubMed ID: 27437939
    [Abstract] [Full Text] [Related]

  • 6. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
    Tissandié E, Morelle W, Berthelot L, Vrtovsnik F, Daugas E, Walker F, Lebrec D, Trawalé JM, Francoz C, Durand F, Moura IC, Paradis V, Moreau R, Monteiro RC.
    Kidney Int; 2011 Dec 05; 80(12):1352-63. PubMed ID: 21866091
    [Abstract] [Full Text] [Related]

  • 7. Role of IgA receptors in the pathogenesis of IgA nephropathy.
    Lechner SM, Papista C, Chemouny JM, Berthelot L, Monteiro RC.
    J Nephrol; 2016 Feb 05; 29(1):5-11. PubMed ID: 26572664
    [Abstract] [Full Text] [Related]

  • 8. Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathy.
    Cambier A, Gleeson PJ, Abbad L, Canesi F, da Silva J, Bex-Coudrat J, Deschênes G, Boyer O, Rabant M, Ulinski T, Hogan J, Peuchmaur M, Berthelot L, Monteiro RC.
    Kidney Int; 2022 Feb 05; 101(2):274-287. PubMed ID: 34756952
    [Abstract] [Full Text] [Related]

  • 9. IgA1 Protease Treatment Reverses Mesangial Deposits and Hematuria in a Model of IgA Nephropathy.
    Lechner SM, Abbad L, Boedec E, Papista C, Le Stang MB, Moal C, Maillard J, Jamin A, Bex-Coudrat J, Wang Y, Li A, Martini PG, Monteiro RC, Berthelot L.
    J Am Soc Nephrol; 2016 Sep 05; 27(9):2622-9. PubMed ID: 26850635
    [Abstract] [Full Text] [Related]

  • 10. Fecal Microbiota Transplantation Modulates Renal Phenotype in the Humanized Mouse Model of IgA Nephropathy.
    Lauriero G, Abbad L, Vacca M, Celano G, Chemouny JM, Calasso M, Berthelot L, Gesualdo L, De Angelis M, Monteiro RC.
    Front Immunol; 2021 Sep 05; 12():694787. PubMed ID: 34712223
    [Abstract] [Full Text] [Related]

  • 11. Mesangial Deposition Can Strongly Involve Innate-Like IgA Molecules Lacking Affinity Maturation.
    Wehbi B, Oblet C, Boyer F, Huard A, Druilhe A, Paraf F, Cogné E, Moreau J, El Makhour Y, Badran B, Van Egmond M, Cogné M, Aldigier JC.
    J Am Soc Nephrol; 2019 Jul 05; 30(7):1238-1249. PubMed ID: 31227634
    [Abstract] [Full Text] [Related]

  • 12. IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.
    Novak J, Moldoveanu Z, Renfrow MB, Yanagihara T, Suzuki H, Raska M, Hall S, Brown R, Huang WQ, Goepfert A, Kilian M, Poulsen K, Tomana M, Wyatt RJ, Julian BA, Mestecky J.
    Contrib Nephrol; 2007 Jul 05; 157():134-8. PubMed ID: 17495451
    [Abstract] [Full Text] [Related]

  • 13. A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy.
    Myette JR, Kano T, Suzuki H, Sloan SE, Szretter KJ, Ramakrishnan B, Adari H, Deotale KD, Engler F, Shriver Z, Wollacott AM, Suzuki Y, Pereira BJG.
    Kidney Int; 2019 Jul 05; 96(1):104-116. PubMed ID: 31027890
    [Abstract] [Full Text] [Related]

  • 14. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
    Berthelot L, Robert T, Vuiblet V, Tabary T, Braconnier A, Dramé M, Toupance O, Rieu P, Monteiro RC, Touré F.
    Kidney Int; 2015 Oct 05; 88(4):815-22. PubMed ID: 26061544
    [Abstract] [Full Text] [Related]

  • 15. Sparsentan ameliorates glomerular hypercellularity and inflammatory-gene networks induced by IgA1-IgG immune complexes in a mouse model of IgA nephropathy.
    Reily C, Moldoveanu Z, Pramparo T, Hall S, Huang ZQ, Rice T, Novak L, Komers R, Jenkinson CP, Novak J.
    Am J Physiol Renal Physiol; 2024 May 01; 326(5):F862-F875. PubMed ID: 38511222
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. LPS/TLR4 Pathway Regulates IgA1 Secretion to Induce IgA Nephropathy.
    He H, Shen M, Tang Y, Sun W, Xu X.
    Altern Ther Health Med; 2024 Jan 01; 30(1):419-425. PubMed ID: 37820669
    [Abstract] [Full Text] [Related]

  • 18. Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy.
    Zhao L, Peng L, Yang D, Chen S, Lan Z, Zhu X, Yuan S, Chen G, Liu Y, Liu H.
    Clin Immunol; 2020 Aug 01; 217():108483. PubMed ID: 32479989
    [Abstract] [Full Text] [Related]

  • 19. TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6-mediated pathways in IgA nephropathy.
    Makita Y, Suzuki H, Kano T, Takahata A, Julian BA, Novak J, Suzuki Y.
    Kidney Int; 2020 Feb 01; 97(2):340-349. PubMed ID: 31748116
    [Abstract] [Full Text] [Related]

  • 20. New insights in the pathogenesis of IgA nephropathy.
    Monteiro RC.
    Nefrologia; 2005 Feb 01; 25 Suppl 2():82-6. PubMed ID: 16050408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.